Calyxt, Inc. Uncategorized Contracts & Agreements

33 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Sale Agreement dated January 2, 2024, by and between Cibus, Inc. and Stifel, Nicolaus & Company, Incorporated
Calyxt, Inc.
Biotechnology
NY
2024
CIBUS, INC. 2017 OMNIBUS INCENTIVE PLAN (F/K/A CALYXT, INC. 2017 OMNIBUS INCENTIVE PLAN) (AS AMENDED, EFFECTIVE MAY 31, 2023)
Calyxt, Inc.
Biotechnology
DE
2023
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS THE TYPE OFINFORMATION THAT THE COMPANY TREATS AS...
Calyxt, Inc.
Biotechnology
2023
CIBUS, INC. INDEMNIFICATION AGREEMENT
Calyxt, Inc.
Biotechnology
DE
2023
THIRD AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF CIBUS GLOBAL, LLC a Delaware limited liability company Dated as of May 31, 2023
Calyxt, Inc.
Biotechnology
DE
2023
TAX RECEIVABLE AGREEMENT among CIBUS, INC. (f/k/aCalyxt, Inc.) and THEPERSONS NAMED HEREIN Dated as of May 31, 2023
Calyxt, Inc.
Biotechnology
DE
2023
EXCHANGE AGREEMENT
Calyxt, Inc.
Biotechnology
DE
2023
REGISTRATION RIGHTS AGREEMENT
Calyxt, Inc.
Biotechnology
DE
2023
Amendment No. 1 to Open Market Sale AgreementSM dated October 3, 2022, by and between Calyxt, Inc. and Jefferies LLC
Calyxt, Inc.
Biotechnology
NY
2022
Open Market Sale AgreementSM dated September 21, 2021, by and between Calyxt, Inc. and Jefferies LLC
Calyxt, Inc.
Biotechnology
NY
2021
Offer Letter between Calyxt, Inc. and Mr. Michael A. Carr, dated July 13, 2021
Calyxt, Inc.
Biotechnology
2021
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Calyxt, Inc.
Biotechnology
DE
2020
Amendment No. 1 to Stockholders Agreement dated May 7, 2018 between Cellectis S.A. and Calyxt, Inc
Calyxt, Inc.
Biotechnology
DE
2018
Offer Letter between Calyxt, Inc. and Manoj Sahoo, dated February 3, 2017
Calyxt, Inc.
Biotechnology
MN
2018
Stockholders Agreement dated July 25, 2017 between Cellectis S.A. and Calyxt, Inc
Calyxt, Inc.
Biotechnology
DE
2018
TERMS AND CONDITIONS OF THE WARRANTS (THE« WARRANTS ») ABSTRACT OF THE MINUTES OF THE BOARD MEETING HELD ON []
Calyxt, Inc.
Biotechnology
2017
CALYXT, INC. 2017 STOCKOPTION SUB-PLAN FOR FRENCH EMPLOYEES AND DIRECTORS
Calyxt, Inc.
Biotechnology
NY
2017
CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. [*****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT...
Calyxt, Inc.
Biotechnology
2017
CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. [*****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT...
Calyxt, Inc.
Biotechnology
2017
CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. [*****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT...
Calyxt, Inc.
Biotechnology
2017
CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. [*****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT...
Calyxt, Inc.
Biotechnology
NY
2017
CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. [*****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT...
Calyxt, Inc.
Biotechnology
MN
2017
TERMS AND CONDITIONS OF THE WARRANTS (THE« WARRANTS ») ABSTRACT OF THE MINUTES OF THE BOARD MEETING HELD ON []
Calyxt, Inc.
Biotechnology
2017
CALYXT, INC. 2017 STOCKOPTION SUB-PLAN FOR FRENCH EMPLOYEES AND CONSULTANTS
Calyxt, Inc.
Biotechnology
NY
2017
600 County Rd D West, Ste8, New Brighton, MN 55112 ###-###-#### www.calyxt.com
Calyxt, Inc.
Biotechnology
MN
2017
EXHIBIT A
Calyxt, Inc.
Biotechnology
MN
2017
CALYXT, INC. EQUITYINCENTIVE PLAN (AS AMENDED)
Calyxt, Inc.
Biotechnology
CA
2017
CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. [*****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT...
Calyxt, Inc.
Biotechnology
2017
CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. [*****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT...
Calyxt, Inc.
Biotechnology
2017
CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. [*****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT...
Calyxt, Inc.
Biotechnology
2017
CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. [*****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT...
Calyxt, Inc.
Biotechnology
NY
2017
CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. [*****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT...
Calyxt, Inc.
Biotechnology
MN
2017
STOCKHOLDERS AGREEMENT by and among CALYXT,INC., CELLECTIS S.A. and the Persons listedon Schedule A hereto Dated as of [], 2017 STOCKHOLDERS AGREEMENT
Calyxt, Inc.
Biotechnology
DE
2017